Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-10-07FDA Approved: ACETAMINOPHEN AND CODEINE PHOSPHATE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for Acetaminophen and Codeine Phosphate from SpecGx LLC under ANDA040419. This action denotes an app…
-
FDA approval · 2019-10-07FDA Approved: TAPENTADOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for tapentadol hydrochloride from Hikma Pharmaceuticals USA Inc., enabling a generic version of tape…
-
FDA approval · 2019-10-07FDA Approved: ROXICODONE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for ROXICODONE (oxycodone hydrochloride) submitted by SpecGx LLC.
-
FDA approval · 2019-10-07FDA Approved: TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Trigen Laboratories, LLC)
FDA approved a supplemental application for tramadol hydrochloride extended-release (Trigen Laboratories, LLC). This action confirms regulat…
-
FDA label_change · 2019-10-07FDA Approved: BUTRANS — Supplemental Application (Purdue Pharma LP)
FDA approved a supplemental application for Butrans (buprenorphine) submitted by Purdue Pharma L.P. The approval may involve changes to the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-10-07FDA Approved: OXAYDO — Supplemental Application (Zyla Life Sciences US LLC)
FDA approves a supplemental application for Oxaydo (oxycodone hydrochloride) by Zyla Life Sciences US LLC.
-
FDA approval · 2019-10-07FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for methadone hydrochloride by Mylan Institutional LLC, resulting in updates to the product labeling…
-
FDA approval · 2019-10-07FDA Approved: BELBUCA — Supplemental Application (BioDelivery Sciences International Inc)
The FDA approved a supplemental application for BELBUCA (buprenorphine hydrochloride) submitted by BioDelivery Sciences International Inc.
-
FDA label_change · 2019-10-07FDA Approved: DISKETS — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for DISKETS (methadone hydrochloride) by Hikma Pharmaceuticals USA Inc., indicating a change to the …
-
FDA approval · 2019-10-07FDA Approved: XTAMPZA ER — Supplemental Application (Collegium Pharmaceutical, Inc.)
The FDA approved a supplemental application for XTAMPZA ER (oxycodone) by Collegium Pharmaceutical, Inc.
-
FDA approval · 2019-10-07FDA Approved: APADAZ — Supplemental Application (Zevra Therapeutics, Inc.)
FDA approved a supplemental application for APADAZ (benzhydrocodone and acetaminophen) from Zevra Therapeutics, Inc.
-
FDA approval · 2019-10-07FDA Approved: BUPRENORPHINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for buprenorphine submitted by Hikma Pharmaceuticals USA Inc., authorizing changes to an approved ge…
-
CLINICAL_TRIALS trial_result · 2019-10-07Clinical Trial Update: Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study [Phase 4]
A Phase 4 randomized, double-blind, placebo-controlled trial evaluating ketamine's effect after laparoscopic gastric reduction (weight loss …
-
FDA label_change · 2019-10-07FDA Approved: MORPHINE SULFATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA documents a supplemental application for Morphine Sulfate by Hikma Pharmaceuticals USA Inc., likely related to labeling changes for the …
-
CLINICAL_TRIALS trial_result · 2019-10-03Clinical Trial Update: Study to Compare Gabapentin to Tramadol in Children With Chronic Neuropathic or Mixed Pain [Phase 3]
Phase 3 trial comparing gabapentin to tramadol in children with chronic neuropathic or mixed pain was terminated.
-
FDA approval · 2019-10-02FDA Approved: METHADONE HYDROCHLORIDE — Original Application (SpecGx LLC)
FDA approved an original application for methadone hydrochloride from SpecGx LLC, resulting in a generic version of this opioid product.
-
CLINICAL_TRIALS trial_result · 2019-09-30Clinical Trial Update: Does Trans-Cutaneous Electrical Nerve Stimulation (TENS) Alleviate The Pain Experienced During Bone Marrow Sampling? [NA]
A completed clinical trial evaluating whether Trans-Cutaneous Electrical Nerve Stimulation (TENS) reduces pain during bone marrow sampling.
-
CLINICAL_TRIALS trial_result · 2019-09-27Clinical Trial Update: Optimizing Pain Control in Transurethral Resection of the Prostate [Phase 4]
Phase 4 clinical trial updating pain control strategies for patients with benign prostatic hyperplasia and urinary obstruction.
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Cannabis Oil for Pain Effectiveness [Phase 2]
Phase 2 clinical trial investigating cannabis oil for pain in cancer patients, status currently unknown.
-
FDA approval · 2019-09-23FDA Approved: BUPRENORPHINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for buprenorphine from Actavis Pharma, Inc., associated with an existing approved product.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Transcutaneous Electrical Nerve Stimulation (TENS) and Head and Neck Cancer Pain (HNC) (TENS & HNC) [NA]
Completed clinical trial investigating transcutaneous electrical nerve stimulation (TENS) for pain in head and neck cancer patients; results…
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain [Phase 3]
Phase 3 trial comparing Oxy/Nal tablets to Oxy PR in cancer-related pain completed; results posted in 2019.
-
CLINICAL_TRIALS withdrawal · 2019-09-12Clinical Trial Update: A Prospective Randomized Comparison of Fentanyl, Methadone and Morphine for Epidural Analgesia in an Experimental Pain Model [Phase 3]
Phase 3 randomized trial comparing fentanyl, methadone, and morphine for epidural analgesia in an experimental pain model was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain [Phase 2, Phase 3]
Phase 2/3 trial update assessing tapentadol tablets in children and adolescents with pain has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: PREMIX vs PREMED Intranasal Lidocaine and Midazolam [Phase 2]
Phase 2 clinical trial comparing PREMIX versus PREMED intranasal lidocaine and midazolam for pain, completed with results posted.